GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Debt-to-EBITDA

Aptamer Group (LSE:APTA) Debt-to-EBITDA : -0.30 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aptamer Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.41 Mil. Aptamer Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.64 Mil. Aptamer Group's annualized EBITDA for the quarter that ended in Dec. 2023 was £-3.50 Mil. Aptamer Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.30.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Aptamer Group's Debt-to-EBITDA or its related term are showing as below:

LSE:APTA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.61   Med: -0.22   Max: -0.17
Current: -0.27

During the past 4 years, the highest Debt-to-EBITDA Ratio of Aptamer Group was -0.17. The lowest was -0.61. And the median was -0.22.

LSE:APTA's Debt-to-EBITDA is ranked worse than
100% of 277 companies
in the Biotechnology industry
Industry Median: 1.36 vs LSE:APTA: -0.27

Aptamer Group Debt-to-EBITDA Historical Data

The historical data trend for Aptamer Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Debt-to-EBITDA Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
Debt-to-EBITDA
-0.17 -0.22 -0.61 -0.23

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial -0.11 -0.57 -0.07 -0.25 -0.30

Competitive Comparison of Aptamer Group's Debt-to-EBITDA

For the Biotechnology subindustry, Aptamer Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptamer Group's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Debt-to-EBITDA falls into.



Aptamer Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aptamer Group's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.314 + 0.764) / -4.765
=-0.23

Aptamer Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.412 + 0.644) / -3.498
=-0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Aptamer Group  (LSE:APTA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Aptamer Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group (LSE:APTA) Business Description

Traded in Other Exchanges
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines